These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3830417)

  • 1. Synthesis and antihypertensive activity of 5-(2-hydroxyphenyl)-1-(3-mercaptopropionyl)-2-pyrrolidinecarboxylic acids.
    Kato E; Yamamoto K; Kawashima Y; Watanabe T; Oya M; Iso T; Iwao J
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):4836-46. PubMed ID: 3830417
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of angiotensin converting enzyme by (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid, SA 446].
    Horiuchi M; Terashima T; Fujimura K; Shimokawa K; Iso T
    Yakugaku Zasshi; 1984 Dec; 104(12):1257-62. PubMed ID: 6099853
    [No Abstract]   [Full Text] [Related]  

  • 4. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N.
    Plummer TH; Ryan TJ
    Biochem Biophys Res Commun; 1981 Jan; 98(2):448-54. PubMed ID: 7225104
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 6. Species difference of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinec arb oxylic acid (SA446) in inhibition of angiotensin converting enzyme.
    Nakata K; Iwatani T; Horiuchi M; Kito H; Yamauchi H; Iso T
    Jpn J Pharmacol; 1986 Mar; 40(3):367-72. PubMed ID: 3012163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a new antihypertensive agent (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid in blood by high-performance liquid chromatography with electrochemical detection.
    Shimada K; Tanaka M; Nambara T; Imai Y
    J Pharm Sci; 1984 Jan; 73(1):119-21. PubMed ID: 6694067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-performance liquid chromatography of organosulfur compounds using the postcolumn ligand exchange reaction with iodoplatinate. Application to the simultaneous determination of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidine carboxylic acid (SA446), an angiotensin converting enzyme inhibitor and its urinary metabolites].
    Horiuchi M; Takashina H; Fujimura K; Iso T
    Yakugaku Zasshi; 1986 Nov; 106(11):1028-33. PubMed ID: 3031265
    [No Abstract]   [Full Text] [Related]  

  • 15. Fast HPLC estimation of gamma-aminobutyric acid in microdialysis perfusates: effect of nipecotic and 3-mercaptopropionic acids.
    Kehr J; Ungerstedt U
    J Neurochem; 1988 Oct; 51(4):1308-10. PubMed ID: 3418350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical thiol surrogates and protective groups for arylthiols for Suzuki-Miyaura conditions.
    Itoh T; Mase T
    J Org Chem; 2006 Mar; 71(5):2203-6. PubMed ID: 16497021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 2-aryliminoimidazolidines. I. Synthesis and antihypertensive properties of 2-(2-phenoxyphenylimino)imidazolidines and related compounds.
    Matsuo M; Taniguchi K; Katsura Y; Kamitani T; Ueda I
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4409-21. PubMed ID: 4092269
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of [3H]- and endogenous GABA from slices of the rat medulla oblongata: modification by 3-mercaptopropionic acid, nipecotic acid and diaminobutyric acid.
    Kihara M; Amano H; Misu Y; Kubo T
    Arch Int Pharmacodyn Ther; 1989; 298():50-60. PubMed ID: 2757467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines].
    Orallo F; Calleja JM; García Mera G; Raviña E
    Arch Farmacol Toxicol; 1985 Dec; 11(3):171-82. PubMed ID: 4096551
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of ketoximino-esters and -ethers as antihypertensive agents.
    Kochhar MM; Williams BB; Fan JH
    J Pharm Sci; 1969 Nov; 58(11):1382-4. PubMed ID: 5349754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.